enVVeno Medical (NVNO) announced the appointment of Jennifer Bright as CFO, effective May 19. Bright brings more than 25 years of financial and strategic leadership experience built across several commercial-stage medical device and pharmaceutical companies including Biolase, Spectrum Pharmaceuticals, Apria Healthcare, Smile Brands, and Teleflex Medical, as well as technical accounting and auditing experience at PricewaterhouseCoopers LLP.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVNO:
- enVVeno Medical publishes three-year VenoValve data
- enVVeno Medical announces publication of VenoValve first-in-human trial data
- Envveno Medical Corporation (NVNO) Q1 Earnings Cheat Sheet
- enVVeno Medical reports Q1 EPS (22c) vs. (31c) last year
- enVVeno Medical expects capital to fund company through several milestones